Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

BACKGROUND: Although total plasma lipoproteome consists of proteins that have shown promises as biomarkers that can identify Alzheimer’s disease (AD), effect sizes are modest. The objective of this study is to provide initial proof-of-concept that the plasma lipoproteome more likely differ between A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Danni, Huang, Fangying, Zhao, Yingchun, Villata, Peter W., Griffin, Timothy J., Zhang, Lin, Li, Ling, Yu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147047/
https://www.ncbi.nlm.nih.gov/pubmed/30250409
http://dx.doi.org/10.1186/s12014-018-9207-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147047/
https://www.ncbi.nlm.nih.gov/pubmed/30250409
http://dx.doi.org/10.1186/s12014-018-9207-z

Ejemplares similares